Premium
Prothena Corporation PLC (PRTA)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product c... Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004). Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.96 | -6.49526387009 | 14.78 | 14.95 | 13.17 | 255959 | 14.0245602 | CS |
| 4 | 0.5 | 3.75375375375 | 13.32 | 16.64 | 13 | 321223 | 14.45804091 | CS |
| 12 | -0.69 | -4.75534114404 | 14.51 | 17.66 | 11.7 | 512909 | 14.41192458 | CS |
| 26 | -6.43 | -31.7530864198 | 20.25 | 22.83 | 11.7 | 485620 | 16.41348479 | CS |
| 52 | -14.95 | -51.9638512339 | 28.77 | 31.03 | 11.7 | 513042 | 20.09252147 | CS |
| 156 | -21.98 | -61.3966480447 | 35.8 | 79.65 | 11.7 | 546491 | 37.99141687 | CS |
| 260 | -0.17 | -1.2151536812 | 13.99 | 79.749 | 6.44 | 469417 | 35.85099448 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
